Jakarta, October 30, 2018 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced its third quarter of year 2018 results. Net sales grew by 3.9% to reach Rp 15,678 billion from Rp 15,090 billion in the same period in 2017. 

Jakarta, 28 October 2018 - PT Kalbe Farma Tbk. (Kalbe) along with the Indonesian Childhood Cancer Foundation (YOAI) inaugurated the Kalbe and YOAI Kids Polyclinic at Dharmais Cancer Hospital, Jakarta. The opening ceremony was conducted by Prof. Dr. dr. Nila Djuwita F. Moeloek SpM (K), Minister of Health of RI; accompanied Irawati Setiady, President Commissioner of PT Kalbe Farma Tbk' and witnessed by Prof. Dr. dr. H. Abdul Kadir, Ph.d, SpTHT-KL (K), MARS, Director Of Dharmais Cancer Hospital; and Rahmi Adi Putra Tahir, Chairperson of the Indonesian Childhood Cancer Foundation.

Jakarta, 26 October 2018 - PT Kalbe Farma Tbk. (Kalbe) along with the Ministry of Research, Technology and Higher Education of the Republic of Indonesia, today again encourages the process of research downstreaming in Indonesia through research funding program Ristekdikti-Kalbe Science Awards (RKSA) 2018. The Rp 1.650 billion fund will be presented to 5 researches in the field of health that has been selected by the Board of Judges chaired by Prof. Dr. Amin Soebandrio, Ph.D, Sp.MK., who is also sitting as the Director of the Eijkman Molecular Biology Agency. The result of the Kalbe-funded research is hoped to be viable to be commercialized and marketed for the public.

In 2-3 October 2018, the Asia Sustainability Reporting Summit (ASRS) 2018 was held at Novotel Clarke Quay, Singapore. ASRS is the meeting point and discussion panel for all Chief Sustainability Officers, top management of Asian companies, maker of standards for sustainability reports, academics, and practitioners of sustainability reports, and other stakeholders from within or outside Asia. The ASRS that was organized by CSRWork for the 2nd time took the theme of: Sustainability Reporting: Beyond Transparency and discussed newest trends in the development of sustainability report from the perspective of investors and how to deliver a report that is trustworthy and of quality.